Skip to main content

Jim Boyle

Equibles does not estimate personal net worth.

About Jim Boyle

Jim Boyle is recorded as Board Member at Medline Inc. (MDLN). Jim Boyle has spoken on 2 earnings calls and 3 other investor events across 1 company, most recently for Medline Inc. on September 15, 2026. Medline Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Medline Inc. includes James M. Boyle (CEO and Board Member), Michael B. Drazin (CFO) and Todd M. Bluedorn (Board Member).

Jim Boyle on recent calls

“Not much about what we've done has changed. When you have 60 years of consecutive growth and you have a playbook that works, changing it isn't the right thing to do. it's always evolving.”
CEO, Morgan Stanley 24th Annual Global Healthcare Conference ·
“The patient safety is the most important thing that we focus on each and every day. And the most recent warning letter was from our ReadyCare Waukegan facility, which is where we make CHG wipes, which is a pre-surgical antiseptic.”
CEO, Goldman Sachs 47th Annual Global Healthcare Conference ·
“I'll begin with a brief performance update for the quarter. Mike will then review our financial results, and I'll close before we open a line for Q&A. Turning to our performance, we started the year with 11% top-line growth in the first quarter, powered by one of our strongest quarters ever in supply chain solutions.”
Board Member, Medline Inc. Q1 FY2026 Earnings Call ·
“Medline is the largest vertically integrated medical surgical manufacturer and supply chain solution provider serving all points of care in health care. Our mission is to make health care run better.”
CEO, Barclays 28th Annual Global Healthcare Conference ·
“Welcome to Medline's fourth quarter and full year 2025 earnings call, our first as a public company following our IPO last December. We appreciate you joining us.”
CEO, Medline Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Medline Inc.

Recent activity